Refractory Chronic Lymphocytic Leukemia

Showing NaN - NaN of 12

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma Trial in

Recruiting
  • Recurrent B-Cell Non-Hodgkin Lymphoma
  • +7 more
  • Autologous Anti-CD19 CAR-expressing T-lymphocytes IC19/1563
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jul 14, 2022

Relapsed Chronic Lymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia, Diffuse Large B Cell Lymphoma Trial in United

Recruiting
  • Relapsed Chronic Lymphocytic Leukemia
  • +4 more
  • Phoenix, Arizona
  • +7 more
Apr 28, 2022

Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Chronic Lymphocytic Leukemia, Recurrent Extranodal Marginal Zone Lymphoma of

Active, not recruiting
  • Recurrent B-Cell Non-Hodgkin Lymphoma
  • +22 more
  • Scottsdale, Arizona
  • +1 more
Aug 10, 2021

B-cell Chronic Lymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia, Stage 0 Chronic Lymphocytic Leukemia Trial in

Completed
  • B-cell Chronic Lymphocytic Leukemia
  • +4 more
  • alemtuzumab
  • +9 more
  • Rochester, Minnesota
    Mayo Clinic
Jun 11, 2020

Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma Trial in Denmark, Italy, United

Completed
  • Chronic Lymphocytic Leukemia
  • +8 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +8 more
  • Rochester, Minnesota
  • +4 more
Jun 20, 2019

Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue, Nodal Marginal Zone Lymphoma, Recurrent Grade 1

Completed
  • Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue
  • +8 more
  • Scottsdale, Arizona
  • +1 more
Apr 4, 2019

Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia Trial in United

Completed
  • Chronic Lymphocytic Leukemia
  • +2 more
  • Akt Inhibitor MK2206
  • +3 more
  • Scottsdale, Arizona
  • +43 more
Aug 17, 2017

B-cell Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia Trial in

Completed
  • B-cell Chronic Lymphocytic Leukemia
  • +2 more
  • sunitinib malate
  • +2 more
  • Rochester, Minnesota
    North Central Cancer Treatment Group
Apr 28, 2014

B-cell Chronic Lymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia Trial in Rochester (bevacizumab)

Completed
  • B-cell Chronic Lymphocytic Leukemia
  • Refractory Chronic Lymphocytic Leukemia
  • bevacizumab
  • Rochester, Minnesota
    Mayo Clinic
Apr 21, 2014

B-cell Chronic Lymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia Trial in Rochester (thalidomide, laboratory

Completed
  • B-cell Chronic Lymphocytic Leukemia
  • Refractory Chronic Lymphocytic Leukemia
  • Rochester, Minnesota
    North Central Cancer Treatment Group
Oct 7, 2013

Refractory Chronic Lymphocytic Leukemia, Refractory Multiple Myeloma, Stage III Multiple Myeloma Trial in Rochester

Completed
  • Refractory Chronic Lymphocytic Leukemia
  • +4 more
  • Rochester, Minnesota
    Mayo Clinic
Mar 18, 2013

B-cell Chronic Lymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia Trial in Rochester (cediranib maleate, laboratory

Completed
  • B-cell Chronic Lymphocytic Leukemia
  • Refractory Chronic Lymphocytic Leukemia
  • cediranib maleate
  • laboratory biomarker analysis
  • Rochester, Minnesota
    North Central Cancer Treatment Group
Jan 14, 2013